Pharmacokinetics of Tasimelteon in Subjects With Mild or Moderate Hepatic Impairment
This study has been completed.
Sponsor:
Vanda Pharmaceuticals
Information provided by (Responsible Party):
Vanda Pharmaceuticals
ClinicalTrials.gov Identifier:
NCT01271387
First received: January 5, 2011
Last updated: October 12, 2011
Last verified: October 2011
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Study Status: | This study has been completed. |
|---|---|
| Study Completion Date: | August 2011 |
| Primary Completion Date: | August 2011 (Final data collection date for primary outcome measure) |